Growing Global Vaccine Market Helping Spur Drug Companies To Pursue Ebola Vaccine

The New Yorker: The Race for an Ebola Vaccine
“…So why this race to create an Ebola vaccine among Merck, GlaxoSmithKline, and Johnson & Johnson — three of the world’s biggest drug manufacturers? … [O]ver the past several years, companies have realized that the difficulties of making vaccines could be an asset, because they can make it more difficult for generic drug companies to create copycat versions than for prescription drugs. The vaccine market has also been growing more quickly than the prescription drug market…” (Vara, 11/25).